RecruitingNot ApplicableNCT07016425

Temporal Interference for Essential Tremor

Efficacy and Safety of Non-invasive Temporal Interference Stimulation in the Treatment of Essential Tremor: A Pilot Trial


Sponsor

Liankun_Ren

Enrollment

10 participants

Start Date

Jun 9, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in essential tremor patients aged 30-70.


Eligibility

Min Age: 30 YearsMax Age: 70 Years

Inclusion Criteria3

  • Aged 30-70 years old, regardless of gender. Action tremor and postural tremor in both upper limbs, or action tremor and postural tremor in one limb;
  • No history of mental diseases;
  • Informed consent signed.

Exclusion Criteria7

  • Presence of other neurological diseases affecting the study (such as epilepsy);
  • Patients with moderate to severe cognitive impairment (Montreal Cognitive Assessment ≤ 18 points);
  • Orthopedic diseases that may affect motor symptoms;
  • Patients taking antipsychotic or antidepressant medications;
  • Presence of metal implants in the body (such as brain pacemakers or cardiac pacemakers);
  • History of electroconvulsive therapy;
  • Presence of cardiovascular risk factors, etc.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTemporal Interference

Researchers apply temporal interference (TI) stimulation to the deep brain nuclei of essential tremor patients.


Locations(1)

Xuanwu Hospital, Capital Medical University

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07016425


Related Trials